CEO Jensen Huang reportedly outlined the redesign strategy during an April trip to Beijing, following a fresh round of U.S. restrictions targeting AI chip exports to China. The company warned in ...

Huang's Beijing trip in mid-April came days after the U.S. government limited exports of its H20 AI chips to China. The export curbs on the primary chip Nvidia was legally permitted to sell in ...

Huang's Beijing trip in mid-April came days after the U.S. government limited exports of its H20 AI chips to China. The export curbs on the primary chip Nvidia was legally permitted to sell in ...

Bolivian authorities are prioritizing the domestic meat demand The Bolivian government's ban on beef exports represents daily losses of approximately US$ 500,000 for the country's cattle farmers ...

More than the adverse impact of tariff-imposed price hikes on US consumers, the US may actually suffer more from supply side economics (export ban) of rare earths. China has near monopoly for ...

(Reuters) - Nvidia has told some of its biggest Chinese customers that it is tweaking the design of its artificial intelligence chips so they can be sold to Chinese businesses without clashing with ...

CEO Jensen Huang reportedly outlined the redesign strategy during an April trip to Beijing, following a fresh round of U.S. restrictions targeting AI chip exports to China. The company warned in its ...

Bangladesh Garment Export Slowdown April 2025: Bangladesh recorded the lowest level of exports so far this fiscal year, both in terms of value and growth, in April as the production of apparel ...

The FDA is moving to ban synthetic food dyes like Red 3 due to health concerns, with a broader ban proposed by Robert F. Kennedy Jr. This initiative will impact a wide range of foods, from cereals ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Bavarian Nordic's Vimkunya (recombinant, adsorbed) vaccine for preventing chikungunya virus ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) isn't sufficiently funded to meet its obligations, according to a new report commissioned by a pharma trade organisation.